JK07 Clinical Trials (2026): 4 Studies for Heart Failure With Preserved Ejection Fraction & Heart Failure With Reduced Ejection Fraction
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
4 JK07 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 3 indications (including Heart Failure With Preserved Ejection Fraction & Heart Failure With Reduced Ejection Fraction) and 296 total planned enrollment. Most recent activity: NCT06369298 (Oct 2026).
JK07 clinical trials at a glance: phase × recruitment status
| Phase | active not recruiting | completed | withdrawn | Total |
|---|---|---|---|---|
| P1 | 1 | 1 | 2 | |
| P2 | 1 | 1 | 2 |
JK07 clinical trials by indication
Heart Failure With Reduced Ejection Fraction (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06369298 | RENEU-HF | P2 | active not recruiting | Study of JK07 in Patients With Chronic Heart Failure |
| NCT04210375 | — | P1 | completed | Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) |
HFrEF - Heart Failure With Reduced Ejection Fraction (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07221513 | RENEU-PH | P2 | withdrawn | Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension |
Heart Failure With Preserved Ejection Fraction (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05322616 | — | P1 | withdrawn | Single-Ascending Dose Study of JK07 in Subjects With HFpEF |
JK07 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| RENEU-HF | NCT06369298 | P2 | active not recruiting | Heart Failure With Reduced Ejection Fraction | 282 | — |
| RENEU-PH | NCT07221513 | P2 | withdrawn | HFrEF - Heart Failure With Reduced Ejection Fraction | 0 | — |
Terminated and withdrawn JK07 trials (2)
Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.
- NCT07221513withdrawnStudy of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
- NCT05322616withdrawnSingle-Ascending Dose Study of JK07 in Subjects With HFpEF
All JK07 trials (4)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06369298 | RENEU-HF | Study of JK07 in Patients With Chronic Heart Failure | P2 | active not recruiting | 282 | Salubris Biotherapeutics Inc | Mar 2024 |
| NCT07221513 | RENEU-PH | Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension | P2 | withdrawn | 0 | Salubris Biotherapeutics Inc | Dec 2025 |
| NCT04210375 | Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) | P1 | completed | 14 | Salubris Biotherapeutics Inc | Sep 2020 | |
| NCT05322616 | Single-Ascending Dose Study of JK07 in Subjects With HFpEF | P1 | withdrawn | 0 | Salubris Biotherapeutics Inc | Oct 2022 |
JK07 clinical trials: frequently asked questions
- How many JK07 clinical trials are there?
- 4 JK07 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is marked completed.
- Are JK07 clinical trials recruiting in 2026?
- No active JK07 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is JK07 being studied for?
- JK07 is being studied for Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction, Group 2 Pulmonary Hypertension, HFpEF - Heart Failure With Preserved Ejection Fraction, HFrEF - Heart Failure With Reduced Ejection Fraction. The trials are grouped by indication on this page.
- What phase is JK07 in?
- JK07 clinical trials span 2 Phase 2, 2 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors JK07 clinical trials?
- The lead sponsor across the most JK07 trials is Salubris Biotherapeutics Inc. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming JK07as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: